Double-Strand Break Repair Pathways Differentially Affect Processing and Transduction by Dual AAV Vectors.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
19 Sep 2023
Historique:
pubmed: 4 10 2023
medline: 4 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

Recombinant adeno-associated viral vectors (rAAV) are a powerful tool for gene delivery but have a limited DNA carrying capacity. Efforts to expand this genetic payload have focused on engineering the vector components, such as dual trans-splicing vectors which double the delivery size by exploiting the natural concatenation of rAAV genomes in host nuclei. We hypothesized that inefficient dual vector transduction could be improved by modulating host factors which affect concatenation. Since factors mediating concatenation are not well defined, we performed a genome-wide screen to identify host cell regulators. We discovered that Homologous Recombination (HR) is inhibitory to dual vector transduction. We demonstrate that depletion or inhibition of HR factors BRCA1 and Rad51 significantly increase reconstitution of a large split transgene by increasing both concatenation and expression from rAAVs. Our results define new roles for DNA damage repair in rAAV transduction and highlight the potential for pharmacological intervention to increase genetic payload of rAAV vectors.

Identifiants

pubmed: 37790316
doi: 10.1101/2023.09.19.558438
pmc: PMC10542147
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : U54 CA231641
Pays : United States

Auteurs

Anna C Maurer (AC)

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
CIRM Center of Excellence, University of California, Berkeley, CA.

Brian Benyamini (B)

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.

Vinson B Fan (VB)

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.

Oscar N Whitney (ON)

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.

Gina M Dailey (GM)

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Li Ka Shing Center for Biomedical & Health Sciences, University of California, Berkeley, CA, USA.

Xavier Darzacq (X)

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Li Ka Shing Center for Biomedical & Health Sciences, University of California, Berkeley, CA, USA.

Matthew D Weitzman (MD)

University of Pennsylvania Perelman School of Medicine and the Children's Hospital of Philadelphia, Philadelphia, PA, USA.

Robert Tjian (R)

Department of Molecular and Cell Biology, University of California, Berkeley, CA, USA.
Li Ka Shing Center for Biomedical & Health Sciences, University of California, Berkeley, CA, USA.
Howard Hughes Medical Institute, University of California, Berkeley, CA, USA.

Classifications MeSH